New Law Boosts Fight Against Sickle Cell Disease
In 2018, the National Institutes of Health was funded approximately 115 million for research of the disease.
In 2018, the National Institutes of Health was funded approximately 115 million for research of the disease.
Children born with sickle cell disease in low-resource regions of the world often remain undiagnosed and therefore do not receive appropriate treatment.
L-Glutamine oral treatment with or without hydroxyurea reduces pain crises better than placebo in individuals with sickle cell disease.
In adults with sickle cell disease, higher daily opioid use may be associated with poorer health-related quality of life.